ROLE OF DENDRITIC CELLS IN CUTANEOUS MALIGNANCY AND AIDS
树突状细胞在皮肤恶性肿瘤和艾滋病中的作用
基本信息
- 批准号:3079156
- 负责人:
- 金额:$ 7.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1985
- 资助国家:美国
- 起止时间:1985-07-01 至 1990-06-30
- 项目状态:已结题
- 来源:
- 关键词:AIDS T lymphocyte antiAIDS agent biological response modifiers biopsy cellular oncology dendritic cells disease /disorder proneness /risk histochemistry /cytochemistry histocompatibility antigens histopathology human immunodeficiency virus 1 human subject human tissue immunofluorescence technique interferons interleukin 1 interleukin 2 laboratory mouse lymph nodes neoplasm /cancer transplantation nucleic acid probes radiation carcinogenesis radiation related neoplasm /cancer skin skin neoplasms squamous cell carcinoma surface antigens tissue /cell culture tissue /cell preparation tumor necrosis factor alpha ultraviolet radiation
项目摘要
The aim of this grant is to test the hypothesis that dendritic cell
(DC) abnormalities might (1) be involved in the pathogenesis of
ultraviolet-B (UVB) induced skin cancers and (2) be at least
partially responsible for the immunologic dysfunctions of the
Acquired Immunodeficiency Syndrome (AIDS). I will continue to
further define the percentage, distribution and phenotypic
characteristics of DC (1) in the skin and lymph modes (LN) of
mice and UVB-induced cutaneous malignancies and (2) in the skin
and LN of patients with AIDS, with AIDS-related complex (ARC)
and with an enhanced risk for developing AIDS. Suitable control
groups will be included throughtout. Epidermal sheets and
cryostat tissue sections of skin and LN will be prepared and
stained for a variety of DC surface antigens, including Ia (HLA-
DR), using immunoperoxidase and immunofluorescent techniques.
In addition, in situ mRNA hybridization will be used to detect the
possibility that DC serve as a reservoir for HIV-1. Where
appropriate, DC suspensions will be made from skin and LN and
analyzed on a FACS 420 cytofluorograph; cytocentrifuge smears
will also be prepared and stained as above. The functional status
of the DC suspensions from LN and skin of tumor-bearing mice
will be evaluated in the MLR. This can be done using T cells
isolated from LN of these mice and from the blood of patients and
assaying the ability of these T cells to proliferate (thymidine
incorporation) and produce interleukin-2. The function of in vitro
HIV-1-infected DC will also be assessed in the autologous MLR
using T cells isolated from the peripheral blood of patients.
Finally, the ability of a variety of lymphokines (interleukin-2,
interferon-delta, tumor necrosis factor) to modulate any observed
defects in cell surface expression and/or antigen-presentation
noted in the functional DC studies will be examined. It is
anticipated that these studies will lead to an increased
understanding of the biology of DC, especially the inter-
relationships among the various DC populations, in normal humans
and mice. In addition, these experiments should provide an
appreciation of the changes in the percentage, distribution,
phenotype and functional properties of DC in patients with
cutaneous malignancies, with AIDS, with ARC and with an
enhanced risk for AIDS. Finally, data on the potential usefulness
of a variety of lymphokines in the treatment of these disorders
will be generated.
这笔赠款的目的是检验树突状细胞的假设
(DC) 异常可能 (1) 参与以下疾病的发病机制
紫外线 B (UVB) 诱发的皮肤癌,并且 (2) 至少
免疫功能障碍的部分原因
获得性免疫缺陷综合症(艾滋病)。 我会继续
进一步定义百分比、分布和表型
DC的特点(1)皮肤和淋巴模式(LN)
小鼠和 UVB 诱发的皮肤恶性肿瘤和 (2) 皮肤
艾滋病相关综合症 (ARC) 患者的 LN 和 LN
并增加患艾滋病的风险。 合适的控制
整个过程中将包括小组。 表皮片和
将制备皮肤和 LN 的低温恒温器组织切片并
对多种 DC 表面抗原进行染色,包括 Ia (HLA-
DR),使用免疫过氧化物酶和免疫荧光技术。
此外,mRNA原位杂交将用于检测
DC 可能是 HIV-1 的储存库。 在哪里
适当的,直流悬浮液将由皮肤和液氮制成,
在 FACS 420 细胞荧光照片上进行分析;细胞离心涂片
也将按照上述方法进行准备和染色。 功能状态
来自荷瘤小鼠的 LN 和皮肤的 DC 悬浮液
将在 MLR 中进行评估。 这可以使用 T 细胞来完成
从这些小鼠的 LN 和患者的血液中分离出来
检测这些 T 细胞增殖的能力(胸苷
并入)并产生白介素-2。 体外功能
HIV-1感染的DC也将在自体MLR中进行评估
使用从患者外周血中分离的 T 细胞。
最后,多种淋巴因子(白细胞介素2,
干扰素-δ、肿瘤坏死因子)来调节任何观察到的
细胞表面表达和/或抗原呈递缺陷
将检查功能性 DC 研究中提到的内容。 这是
预计这些研究将导致增加
了解 DC 的生物学,特别是间
正常人中不同 DC 群体之间的关系
和老鼠。 此外,这些实验应该提供
欣赏百分比、分布的变化,
DC患者的表型和功能特性
皮肤恶性肿瘤、艾滋病、ARC 和
增加患艾滋病的风险。 最后,关于潜在用途的数据
多种淋巴因子在治疗这些疾病中的作用
将被生成。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Enhancement by various cytokines or 2-beta-mercaptoethanol of Ia antigen expression on Langerhans cells in skin from normal aged and young mice. Effect of cyclosporine A.
各种细胞因子或 2-β-巯基乙醇增强正常老年和年轻小鼠皮肤朗格汉斯细胞上 Ia 抗原的表达。
- DOI:
- 发表时间:1989
- 期刊:
- 影响因子:0
- 作者:Belsito,DV;Epstein,SP;Schultz,JM;Baer,RL;Thorbecke,GJ
- 通讯作者:Thorbecke,GJ
Effect of triggering epidermal Fc gamma receptors on the interleukin-2- and interleukin-6-induced upregulation of Ia antigen expression by murine epidermal Langerhans cells: the role of prostaglandins and cAMP.
触发表皮 Fc γ 受体对白细胞介素 2 和白细胞介素 6 诱导的小鼠表皮朗格汉斯细胞 Ia 抗原表达上调的影响:前列腺素和 cAMP 的作用。
- DOI:10.1111/1523-1747.ep12481477
- 发表时间:1991
- 期刊:
- 影响因子:0
- 作者:Epstein,SP;Baer,RL;Belsito,DV
- 通讯作者:Belsito,DV
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DONALD V BELSITO其他文献
DONALD V BELSITO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DONALD V BELSITO', 18)}}的其他基金
ROLE OF DENDRITIC CELLS IN CUTANEOUS MALIGNANCY AND AIDS
树突状细胞在皮肤恶性肿瘤和艾滋病中的作用
- 批准号:
3079155 - 财政年份:1985
- 资助金额:
$ 7.58万 - 项目类别:
ROLE OF DENDRITIC CELLS IN CUTANEOUS MALIGNANCY AND AIDS
树突状细胞在皮肤恶性肿瘤和艾滋病中的作用
- 批准号:
3079153 - 财政年份:1985
- 资助金额:
$ 7.58万 - 项目类别:
ROLE OF DENDRITIC CELLS IN CUTANEOUS MALIGNANCY AND AIDS
树突状细胞在皮肤恶性肿瘤和艾滋病中的作用
- 批准号:
3079070 - 财政年份:1985
- 资助金额:
$ 7.58万 - 项目类别:
ROLE OF DENDRITIC CELLS IN CUTANEOUS MALIGNANCY AND AIDS
树突状细胞在皮肤恶性肿瘤和艾滋病中的作用
- 批准号:
3079154 - 财政年份:1985
- 资助金额:
$ 7.58万 - 项目类别:
相似海外基金
Modulation of T lymphocyte Activation by Ã2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
RGPIN-2019-06980 - 财政年份:2022
- 资助金额:
$ 7.58万 - 项目类别:
Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10581488 - 财政年份:2022
- 资助金额:
$ 7.58万 - 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574979-2022 - 财政年份:2022
- 资助金额:
$ 7.58万 - 项目类别:
University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10332251 - 财政年份:2022
- 资助金额:
$ 7.58万 - 项目类别:
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574984-2022 - 财政年份:2022
- 资助金额:
$ 7.58万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574985-2022 - 财政年份:2022
- 资助金额:
$ 7.58万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574978-2022 - 财政年份:2022
- 资助金额:
$ 7.58万 - 项目类别:
University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
- 批准号:
444149 - 财政年份:2021
- 资助金额:
$ 7.58万 - 项目类别:
Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
- 批准号:
RGPIN-2015-05491 - 财政年份:2021
- 资助金额:
$ 7.58万 - 项目类别:
Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
- 批准号:
RGPIN-2019-06980 - 财政年份:2021
- 资助金额:
$ 7.58万 - 项目类别:
Discovery Grants Program - Individual